| 價(jià)格 | 詢價(jià) |
| 包裝 | 25μg |
| 最小起訂量 | 25μg |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2026-05-24 |
| 英文名稱:APC anti-human CD19 | 產(chǎn)品類別: 抗體 |
APC anti-human CD19 Antibody
Catalog# 1 Size 302211 125 tests
3022121 100 tests
Clone HIB19
Workshop V CD19.11
Other Names B4
Isotype Mouse lgG1, K
Description CD19 is a 95 kD type I transmembrane glycoprotein also known as B4. Itis a member of the
immunoglobulin superfamily expressed on B-cells (rom pro-B to blastoid B cells, absent on
plasma cells) and fllicular dendritic cells. CD19 is involved in B cell development,
activation, and diferentiation. CD19 forms a complex with CD21 (CR2) and CD81 (TAPA-1),
and functions as a BCR co-receptor.
Product Details
Reactivity Human, Chimpanzee, Rhesus
Antibody Type Monoclonal
Host Species Mouse
Formulation Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (wV) BSA (origin
USA).
Preparation The antibody was purified by afinity chromatography, and conjugated with APC under optimal
conditions.
Concentration Lot-specific (please contact technical support for concentration and total μg amount, or use our Lookup
tool if you have a lot number)
Storage & Handling The CD19 antibody solution should be stored undiluted between 2°C and 8°C, and protected from ;
prolonged exposure to light. Do not freeze.
Application FC - Quality tested
Recommended Usage Each lot of this antibody is quality control tested by immunofluorescent staining with flow
cytometric
analysis. For flow cytometric staining, the suggested use of this reagent is 5 μ per million cells in 100
μl staining volume or 5 μl per 100 μl of whole blood.
| 成立日期 | 2014-11-20 (12年) | 注冊(cè)資本 | 10萬(wàn)人民幣 |
| 員工人數(shù) | 50-100人 | 年?duì)I業(yè)額 | ¥ 100萬(wàn)-300萬(wàn) |
| 主營(yíng)行業(yè) | 生物化工 | 經(jīng)營(yíng)模式 | 工廠,試劑 |
| 產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| 詢價(jià) |
北京泰澤嘉業(yè)科技發(fā)展有限公司
|
2026-05-24 | ||
| ¥960.00 |
VIP10年
|
北京索萊寶科技有限公司
|
2026-06-08 | |
| ¥1580 |
VIP4年
|
上海滬震實(shí)業(yè)有限公司
|
2026-06-08 | |
| ¥3192 |
VIP5年
|
上海博爾森生物科技有限公司
|
2026-06-08 |